Next Generation Biomanufacturing Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Next Generation Biomanufacturing Market: By Type (Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, Downstream Biomanufacturing) Application (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins Others) End-Use (Biopharmaceutical Companies, Research Institutions, CMOs/CDMOs) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Next Generation Biomanufacturing Market Introduction
2.1. Global Next Generation Biomanufacturing Market – Taxonomy
2.2. Global Next Generation Biomanufacturing Market –Definitions
2.2.1. By Type
2.2.2. By Application
2.2.3. By End-Use
3. Global Next Generation Biomanufacturing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Next Generation Biomanufacturing Market Dynamic Factors – Impact Analysis
3.6. Global Next Generation Biomanufacturing Market – Competition Landscape
3.7. Epidemiology
4. Global Next Generation Biomanufacturing Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Next Generation Biomanufacturing Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Continuous Upstream Biomanufacturing
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Single-Use Upstream Biomanufacturing
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Downstream Biomanufacturing
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Next Generation Biomanufacturing Market Forecast, Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Monoclonal Antibodies
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Hormones
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Vaccines
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Recombinant Proteins
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Next Generation Biomanufacturing Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Biopharmaceutical Companies
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Research Institutions
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. CMOs/CDMOs
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Next Generation Biomanufacturing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Region, 2022-2028
9. North America Next Generation Biomanufacturing MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Continuous Upstream Biomanufacturing
9.1.2. Single-Use Upstream Biomanufacturing
9.1.3. Downstream Biomanufacturing
9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Monoclonal Antibodies
9.2.2. Hormones
9.2.3. Vaccines
9.2.4. Recombinant Proteins
9.2.5. Others
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Biopharmaceutical Companies
9.3.2. Research Institutions
9.3.3. CMOs/CDMOs
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
9.6. North America Next Generation Biomanufacturing Market Dynamics – Trends
10. Europe Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Continuous Upstream Biomanufacturing
10.1.2. Single-Use Upstream Biomanufacturing
10.1.3. Downstream Biomanufacturing
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Monoclonal Antibodies
10.2.2. Hormones
10.2.3. Vaccines
10.2.4. Recombinant Proteins
10.2.5. Others
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Biopharmaceutical Companies
10.3.2. Research Institutions
10.3.3. CMOs/CDMOs
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
10.6. Europe Next Generation Biomanufacturing Market Dynamics – Trends
11. Asia-Pacific Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Continuous Upstream Biomanufacturing
11.1.2. Single-Use Upstream Biomanufacturing
11.1.3. Downstream Biomanufacturing
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Monoclonal Antibodies
11.2.2. Hormones
11.2.3. Vaccines
11.2.4. Recombinant Proteins
11.2.5. Others
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Biopharmaceutical Companies
11.3.2. Research Institutions
11.3.3. CMOs/CDMOs
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
11.6. Asia-Pacific Next Generation Biomanufacturing Market Dynamics – Trends
12. Latin America Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Continuous Upstream Biomanufacturing
12.1.2. Single-Use Upstream Biomanufacturing
12.1.3. Downstream Biomanufacturing
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Monoclonal Antibodies
12.2.2. Hormones
12.2.3. Vaccines
12.2.4. Recombinant Proteins
12.2.5. Others
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Biopharmaceutical Companies
12.3.2. Research Institutions
12.3.3. CMOs/CDMOs
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
12.6. Latin America Next Generation Biomanufacturing Market Dynamics – Trends
13. Middle East and Africa Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Continuous Upstream Biomanufacturing
13.1.2. Single-Use Upstream Biomanufacturing
13.1.3. Downstream Biomanufacturing
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Monoclonal Antibodies
13.2.2. Hormones
13.2.3. Vaccines
13.2.4. Recombinant Proteins
13.2.5. Others
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Biopharmaceutical Companies
13.3.2. Research Institutions
13.3.3. CMOs/CDMOs
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
13.6. MEA Next Generation Biomanufacturing Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Merck KGaA
14.2.2. Thermo Fisher Scientific Inc.,
14.2.3. Eppendorf AG
14.2.4. Danaher Corporation
14.2.5. GEA Group Aktiengesellschaft
14.2.6. Sartorius AG
14.2.7. bbi-biotech GmbH
14.2.8. Solaris Biotechnology Srl
14.2.9. Esco Group of Companies
14.2.10. Modern Meadow
15. Research Methodology
16. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Merck KGaA
  • Thermo Fisher Scientific Inc.,
  • Eppendorf AG
  • Danaher Corporation
  • GEA Group Aktiengesellschaft
  • Sartorius AG
  • bbi-biotech GmbH
  • Solaris Biotechnology Srl
  • Esco Group of Companies
  • Modern Meadow

Description

1. Executive Summary
2. Global Next Generation Biomanufacturing Market Introduction
2.1. Global Next Generation Biomanufacturing Market – Taxonomy
2.2. Global Next Generation Biomanufacturing Market –Definitions
2.2.1. By Type
2.2.2. By Application
2.2.3. By End-Use
3. Global Next Generation Biomanufacturing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Next Generation Biomanufacturing Market Dynamic Factors – Impact Analysis
3.6. Global Next Generation Biomanufacturing Market – Competition Landscape
3.7. Epidemiology
4. Global Next Generation Biomanufacturing Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Next Generation Biomanufacturing Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Continuous Upstream Biomanufacturing
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Single-Use Upstream Biomanufacturing
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Downstream Biomanufacturing
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Next Generation Biomanufacturing Market Forecast, Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Monoclonal Antibodies
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Hormones
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Vaccines
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Recombinant Proteins
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Next Generation Biomanufacturing Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Biopharmaceutical Companies
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Research Institutions
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. CMOs/CDMOs
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Next Generation Biomanufacturing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Region, 2022-2028
9. North America Next Generation Biomanufacturing MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Continuous Upstream Biomanufacturing
9.1.2. Single-Use Upstream Biomanufacturing
9.1.3. Downstream Biomanufacturing
9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Monoclonal Antibodies
9.2.2. Hormones
9.2.3. Vaccines
9.2.4. Recombinant Proteins
9.2.5. Others
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Biopharmaceutical Companies
9.3.2. Research Institutions
9.3.3. CMOs/CDMOs
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
9.6. North America Next Generation Biomanufacturing Market Dynamics – Trends
10. Europe Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Continuous Upstream Biomanufacturing
10.1.2. Single-Use Upstream Biomanufacturing
10.1.3. Downstream Biomanufacturing
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Monoclonal Antibodies
10.2.2. Hormones
10.2.3. Vaccines
10.2.4. Recombinant Proteins
10.2.5. Others
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Biopharmaceutical Companies
10.3.2. Research Institutions
10.3.3. CMOs/CDMOs
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
10.6. Europe Next Generation Biomanufacturing Market Dynamics – Trends
11. Asia-Pacific Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Continuous Upstream Biomanufacturing
11.1.2. Single-Use Upstream Biomanufacturing
11.1.3. Downstream Biomanufacturing
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Monoclonal Antibodies
11.2.2. Hormones
11.2.3. Vaccines
11.2.4. Recombinant Proteins
11.2.5. Others
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Biopharmaceutical Companies
11.3.2. Research Institutions
11.3.3. CMOs/CDMOs
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
11.6. Asia-Pacific Next Generation Biomanufacturing Market Dynamics – Trends
12. Latin America Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Continuous Upstream Biomanufacturing
12.1.2. Single-Use Upstream Biomanufacturing
12.1.3. Downstream Biomanufacturing
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Monoclonal Antibodies
12.2.2. Hormones
12.2.3. Vaccines
12.2.4. Recombinant Proteins
12.2.5. Others
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Biopharmaceutical Companies
12.3.2. Research Institutions
12.3.3. CMOs/CDMOs
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
12.6. Latin America Next Generation Biomanufacturing Market Dynamics – Trends
13. Middle East and Africa Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Continuous Upstream Biomanufacturing
13.1.2. Single-Use Upstream Biomanufacturing
13.1.3. Downstream Biomanufacturing
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Monoclonal Antibodies
13.2.2. Hormones
13.2.3. Vaccines
13.2.4. Recombinant Proteins
13.2.5. Others
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Biopharmaceutical Companies
13.3.2. Research Institutions
13.3.3. CMOs/CDMOs
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Next Generation Biomanufacturing Market – Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028
13.6. MEA Next Generation Biomanufacturing Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Merck KGaA
14.2.2. Thermo Fisher Scientific Inc.,
14.2.3. Eppendorf AG
14.2.4. Danaher Corporation
14.2.5. GEA Group Aktiengesellschaft
14.2.6. Sartorius AG
14.2.7. bbi-biotech GmbH
14.2.8. Solaris Biotechnology Srl
14.2.9. Esco Group of Companies
14.2.10. Modern Meadow
15. Research Methodology
16. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX